Calleja S, Rodriguez-Lopez A, Ochoa D, Luquero S, Navares-Gomez M, Roman M
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40005966
PMC: 11860030.
DOI: 10.3390/ph18020151.
Yang Y, Del Gaudio D, Santani A, Scott S
Genet Med Open. 2025; 2():101840.
PMID: 39822265
PMC: 11736070.
DOI: 10.1016/j.gimo.2024.101840.
Abdelazim A, Maged M, Abdelmaksoud A, Hassanein S
Sci Rep. 2025; 15(1):2153.
PMID: 39819897
PMC: 11739396.
DOI: 10.1038/s41598-025-85595-x.
Gonzalez-Iglesias E, Mendez-Ponce C, Ochoa D, Roman M, Mejia-Abril G, Martin-Vilchez S
Int J Mol Sci. 2025; 26(1.
PMID: 39796117
PMC: 11720188.
DOI: 10.3390/ijms26010260.
Holt J, Harting J, Chen X, Baker D, Saunders C, Kronenberg Z
bioRxiv. 2024; .
PMID: 39713404
PMC: 11661245.
DOI: 10.1101/2024.12.10.627527.
Customizing the electronic health record for delivery of pharmacogenetics.
Hoffecker G, Varughese L, Bleznuck J, Landgraf J, Wollack C, Chen J
Genet Med Open. 2024; 1(1):100779.
PMID: 39669236
PMC: 11613548.
DOI: 10.1016/j.gimo.2023.100779.
Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer?.
Wong A, Vogrin S, Klepstad P, Rubio J, Le B, Philip J
Pharmacogenomics. 2024; 25(14-15):579-586.
PMID: 39628313
PMC: 11703413.
DOI: 10.1080/14622416.2024.2430161.
French-Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten.
Lebreton L, Boyer J, Lafay-Chebassier C, Hennart B, Baklouti S, Cunat S
Clin Pharmacol Ther. 2024; 117(2):387-397.
PMID: 39584620
PMC: 11739748.
DOI: 10.1002/cpt.3502.
Genetic ancestry in population pharmacogenomics unravels distinct geographical patterns related to drug toxicity.
Karamperis K, Katz S, Melograna F, Ganau F, Van Steen K, Patrinos G
iScience. 2024; 27(10):110916.
PMID: 39391720
PMC: 11465127.
DOI: 10.1016/j.isci.2024.110916.
Dopamine Transporter and Gene Relationships with Attention-Deficit/Hyperactivity Disorder Treatment Response in the Methylphenidate and Atomoxetine Crossover Study.
Bishop J, Zhou C, Gaedigk A, Krone B, Kittles R, Cook E
J Child Adolesc Psychopharmacol. 2024; 34(10):458-469.
PMID: 39387268
PMC: 11807865.
DOI: 10.1089/cap.2024.0069.
Development and validation of next-generation sequencing panel for personalized eradication treatment targeting multiple species.
Min B, Seo M, Bae J, Kim J, Kim J
Front Cell Infect Microbiol. 2024; 14:1379790.
PMID: 39268485
PMC: 11390507.
DOI: 10.3389/fcimb.2024.1379790.
Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis.
Kaptsis D, Lewis M, Sorich M, Battersby M
J Psychopharmacol. 2024; 38(9):771-783.
PMID: 39262167
PMC: 11447996.
DOI: 10.1177/02698811241268899.
Genetic Determinants of Response to P2Y Inhibitors and Clinical Implications.
Cavallari L, Coons J
Interv Cardiol Clin. 2024; 13(4):469-481.
PMID: 39245547
PMC: 11483879.
DOI: 10.1016/j.iccl.2024.06.002.
copy number determination using digital PCR.
Wang W, Lin L, Boone E, Stevens J, Gaedigk A
Front Pharmacol. 2024; 15:1429286.
PMID: 39206265
PMC: 11349684.
DOI: 10.3389/fphar.2024.1429286.
PharmVar GeneFocus: CYP4F2.
Zubiaur P, Rodriguez-Antona C, Boone E, Daly A, Tsermpini E, Khasawneh L
Clin Pharmacol Ther. 2024; 116(4):963-975.
PMID: 39135485
PMC: 11452279.
DOI: 10.1002/cpt.3405.
Characterization of Reference Materials for DPYD: A GeT-RM Collaborative Project.
Gaedigk A, Turner A, Moyer A, Zubiaur P, Boone E, Wang W
J Mol Diagn. 2024; 26(10):864-875.
PMID: 39032822
PMC: 11818935.
DOI: 10.1016/j.jmoldx.2024.06.004.
The variation landscape of CYP2D6 in a multi-ethnic Asian population.
Maulana Y, Jimenez R, Twesigomwe D, Sani L, Irwanto A, Bertin N
Sci Rep. 2024; 14(1):16725.
PMID: 39030343
PMC: 11271511.
DOI: 10.1038/s41598-024-67691-6.
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.
Duarte J, Thomas C, Lee C, Huddart R, Agundez J, Baye J
Clin Pharmacol Ther. 2024; 116(4):939-947.
PMID: 38951961
PMC: 11502236.
DOI: 10.1002/cpt.3351.
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy.
Robinson K, Eum S, Desta Z, Tyndale R, Gaedigk A, Crist R
Clin Pharmacol Ther. 2024; 116(4):932-938.
PMID: 38863207
PMC: 11587193.
DOI: 10.1002/cpt.3338.
A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data.
John S, Klumsathian S, Own-Eium P, Eu-Ahsunthornwattana J, Sura T, Dejsuphong D
Clin Transl Sci. 2024; 17(6):e13830.
PMID: 38853370
PMC: 11163017.
DOI: 10.1111/cts.13830.
